Hypertension Drugs Market 2016-2020

  • Published: Apr 2016
  • Pages: 87
  • SKU: IRTNTR9233

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

This market research report presents a detailed segmentation of the global hypertension drugs market by type (systemic hypertension drugs and pulmonary hypertension drugs) and by geography (Americas, APAC, and EMEA). Some of the vendors in the market are Novartis, Daiichi Sankyo, Actelion Pharmaceuticals, Boehringer Ingelheim, Sanofi, and AstraZeneca.

The outlook of the hypertension drugs market

Extensive research carried out by the analysts at Technavio has shown that the global hypertension drugs market will post an impressive market value of USD 32 billion by the end of 2020. With an increase in the population of older people, the market for hypertension drugs has a positive outlook over the forecast period. The prevalence of hypertension is high among the older population with close to 70% of the patients with high BP above the age of 60. Currently, close to 11% of the global population is aged 60 years or over and is estimated to reach nearly 22% by 2050. Since the risk of developing pulmonary hypertension increases with age, a growing older population will aid in the growth prospects of the hypertension drugs market size in the coming years. 

Hypertension drugs market drivers

In this industry research report, the analysts have estimated factors like the growing awareness of hypertension and it's treatment options to impel this market’s growth prospects until the end of 2020.  Enhanced patient awareness results in an early diagnosis of the disease followed by treatment. For instance, the National Heart, Lung, and Blood Institute of National Institutes of Health launched the High Blood Pressure Education program which is a cooperative effort among professionals, voluntary health agencies, and state health departments with a goal to cut down death and disability related to hypertension through several professional programs, patient interaction, and public education. Similarly, 17th May is celebrated as the World Hypertension Day every year by the International Society of Hypertension. Such events and resources increase awareness among people and are expected to drive the market growth for hypertension drugs during the forecast period.

Hypertension drugs market segmentation by type

  • Systemic hypertension drugs
  • Pulmonary hypertension drugs

During 2015, the systemic hypertension drugs segment dominated the hypertension drugs market and accounted for close to 87% of the market share. However, the market segment is expected to witness a decline in the forecast period because of patent expiries of drugs, followed by generic erosion. The systemic hypertension drugs market is expected to reach more than USD 27 billion by the end of 2020.

Hypertension drugs market based on geographical segmentation 

  • Americas
  • APAC
  • EMEA

In 2015, the Americas was the largest market for hypertension drugs as it accounted for more than 44% of the market share. The US is the major revenue contributor in the region. The market share is declining due to the patent expiries of drugs such as Micardis, Avapro, and Diovan. However, comorbid conditions among the older population like congenital heart disease and increasing focus on combination therapies will prevent the decline in the market. Moreover, the launch of new disease-modifying therapies is expected to bolster the growth prospects of the market during the forecast period.

Hypertension drugs market: Competitive landscape and key vendors

The global market for the hypertension drugs is high consolidated due to the presence of a few well-established vendors. At present, the market is declining because of the increased use of generic drugs. Therefore, companies are investing heavily in the development of new medicines for the treatment of hypertension.

Key vendors in the hypertension drugs market

  • Novartis
  • Daiichi Sankyo
  • Actelion Pharmaceuticals
  • Boehringer Ingelheim
  • Sanofi
  • Pfizer

Other prominent vendors in the market are Actelion Pharmaceuticals, Arena Pharmaceuticals, Asahi Kasei, Bayer HealthCare, Bellerophon Therapeutics, Bial, CJ HealthCare, Conatus Pharmaceuticals, Deka Pharmaceuticals, Dong-A ST, Eiger BioPharmaceuticals, Forest Laboratories, Gilead Sciences, HanAll BioPharma, Hanmi Pharmaceutical, Johnson & Johnson, LG Life Sciences, Lung Biotechnology, Lupin Pharmaceuticals, Mast Therapeutics, Merck, Northern Therapeutics, Ono Pharmaceutical,

Pfizer, PhaseBio, Pluristem Therapeutics, Quantum Genomics, Radikal Therapeutics, Reata Pharmaceuticals, Serodus, sigma-tau i.f.r, SteadyMed Therapeutics, Suda, Sun Pharmaceutical Industries, Symplmed Pharmaceuticals, Takeda Pharmaceuticals, United Therapeutics, Valeant Pharmaceuticals, XOMA, and Yuhan.

Key questions answered in the report include

  • What will the hypertension drugs market size and growth rate be in 2020?
  • What are the key factors driving the global hypertension drugs market?
  • What are the key market trends impacting the growth of the global hypertension drugs market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global hypertension drugs market?
  • What are the market opportunities and threats faced by the vendors in the global hypertension drugs market?
  • Trending factors influencing the market shares of the Americas, APAC, and EMEA.
  • What are the key outcomes of the five forces analysis of the global hypertension drugs market?

Technavio also offers customization on reports based on specific client requirement.

Related reports



Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of  the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights
  • Key buying criteria

PART 05: Cardiovascular drugs market

  • Global pharmaceuticals market
  • Global cardiovascular drugs market

PART 06: Overview: Hypertension

  • Systemic hypertension
  • PAH

PART 07: Epidemiology and economic burden

  • Economic burden

PART 08: Pipeline portfolio

PART 09: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 10: Market segmentation by type

  • Global systemic hypertension drugs market
  • Global PAH drugs market

PART 11: Market segmentation by drug class

  • Systemic hypertension
  • PAH

PART 12: Geographical segmentation

  • Global hypertension drugs market by geographical segmentation 2015-2020
  • Hypertension drugs market in Americas
  • Hypertension drugs market in EMEA
  • Hypertension drugs market in APAC

PART 13: Market drivers

  • Growing older population
  • Rise in sedentary lifestyle
  • High prevalence of chronic conditions
  • Patient assistance programs

PART 14: Impact of drivers

PART 15: Market challenges

  • Patent expiries of major drugs
  • Adverse effects
  • Poor patient compliance
  • Availability of alternative therapies

PART 16: Impact of drivers and challenges

PART 17: Market trends

  • Increase in awareness
  • Increased focus on combination therapies
  • Intense competition among vendors
  • Strategic alliances

PART 18: Vendor landscape

  • Competitive scenario
  • Market share 2015
  • Novartis
  • Daiichi Sankyo
  • Actelion Pharmaceuticals
  • Boehringer Ingelheim
  • Sanofi
  • AstraZeneca
  • Other prominent vendors

PART 19: Appendix

  • List of abbreviations

PART 20: Explore Technavio

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.


Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases


Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts



  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis


  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted

  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>